Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 22 analyst ratings
Buy
Strong Buy 27%
Buy 59%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

UnitedHealth Group is a leading player in the healthcare insurance industry, with a large scale and diverse portfolio of products and services. They have shown strong financial performance and continue to increase guidance and targets. The company is well-positioned for future growth and maintains a positive outlook from analysts.

Bears say

UnitedHealth Group is facing elevated medical costs, which have impacted its Medical Loss Ratio and may continue to do so in the future. While its Optum business provides diversification and potential for growth, concerns about cost containment and competition in the insurance industry warrant a negative outlook as the company navigates through ongoing healthcare industry changes. Additionally, the company's strong 2Q performance and raised FY guidance may not be sustainable in the long term, casting doubts on the long-term growth potential and profitability of UnitedHealth Group.

UnitedHealth Group (UNH) has been analyzed by 22 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 59% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 22 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $454.09, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $454.09, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.